BioCentury | Feb 3, 2021
Product Development

Amgen reiterates focus on protein degradation, details setbacks to four early-stage cancer programs

...2019 takeout of DNA-encoded library (DEL) company Nuevolution.“The...
BioCentury | May 9, 2020
Product Development

With Nuevolution’s DNA-encoded libraries, Amgen takes on targeted degradation and beyond

...Amgen’s 2019 takeout of DNA-encoded library (DEL) company Nuevolution is fueling the big biotech’s move into...
...Platform “precipitated our desire to acquire access to DEL technology.” Amgen acquired Danish DEL company Nuevolution...
...on their phenotypic effects, and only later shown to bring multiple targets together. Deshaies thinks Nuevolution’s...
BioCentury | Sep 13, 2019
Tools & Techniques

Getting higher-quality hits out of DNA-encoded libraries

...competing DEL providers X-Chem Inc. and Nuevolution AB (see “HitGen’s DNA for Small Molecules” ). Nuevolution...
...methods to sift through the data. Amgen Inc. is using a chemoinformatics platform developed by Nuevolution...
...needed. The compatibility of DEL with affinity-based screens was a driver of Amgen’s acquisition of Nuevolution...
BioCentury | Aug 23, 2019
Company News

HotSpot acquires Macroceutics for focused allosteric library

...Nuevolution AB (SSE:NUE) for about $167 million in cash (see "Amgen Proposes to Acquire Partner Nuevolution"...
BioCentury | Jul 12, 2019
Financial News

HitGen joins growing Shanghai IPO queue

...myeloma. According to the company's prospectus, HitGen's partnerships outnumber those of competing DEL service companies Nuevolution...
...deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...
BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...Pfizer Inc. (NASDAQ:PFE) Array Biopharma Inc. (NASDAQ:ARRY) 06/17/19 $10,644.0 NA NA $10,644.0 Amgen Inc. (NASDAQ:AMGN) Nuevolution...
BioCentury | May 22, 2019
Company News

In a rare M&A move, Amgen proposes to acquire partner Nuevolution

...first acquisition since 2015, Amgen offered on Wednesday to buy Copenhagen-based small molecule discovery company Nuevolution...
...the deal would enable Amgen to more closely integrate Nuevolution's discovery platform into Amgen's research. Nuevolution's...
...million up front. Nuevolution gained SEK20.10 (166%) to SEK32.20 on Wednesday. Elizabeth S. Eaton, Staff Writer Amgen Inc. Nuevolution...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...whole industry.” Jin Li, HitGen HitGen has two principal competitors: Massachusetts-based X-Chem Inc. and Copenhagen-based Nuevolution...
...compounds, and has 22 collaborations, which have yielded more than 50 licenses to its partners. Nuevolution...
...what it considered the three leading companies in the DEL space -- HitGen, X-Chem and Nuevolution...
BioCentury | Jan 24, 2018
Company News

Management tracks: Gritstone, Disarm, Symic

...Billbäck, who was a senior advisor at Essity Aktiebolag (SSE:ESSITY). Small molecule drug discovery company Nuevolution...
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...and Phase I testing for renal diseases and AD. Two other companies, Dybly AG and Nuevolution...
...Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. MPM Capital, South San Francisco, Calif. Nuevolution...
Items per page:
1 - 10 of 54
BioCentury | Feb 3, 2021
Product Development

Amgen reiterates focus on protein degradation, details setbacks to four early-stage cancer programs

...2019 takeout of DNA-encoded library (DEL) company Nuevolution.“The...
BioCentury | May 9, 2020
Product Development

With Nuevolution’s DNA-encoded libraries, Amgen takes on targeted degradation and beyond

...Amgen’s 2019 takeout of DNA-encoded library (DEL) company Nuevolution is fueling the big biotech’s move into...
...Platform “precipitated our desire to acquire access to DEL technology.” Amgen acquired Danish DEL company Nuevolution...
...on their phenotypic effects, and only later shown to bring multiple targets together. Deshaies thinks Nuevolution’s...
BioCentury | Sep 13, 2019
Tools & Techniques

Getting higher-quality hits out of DNA-encoded libraries

...competing DEL providers X-Chem Inc. and Nuevolution AB (see “HitGen’s DNA for Small Molecules” ). Nuevolution...
...methods to sift through the data. Amgen Inc. is using a chemoinformatics platform developed by Nuevolution...
...needed. The compatibility of DEL with affinity-based screens was a driver of Amgen’s acquisition of Nuevolution...
BioCentury | Aug 23, 2019
Company News

HotSpot acquires Macroceutics for focused allosteric library

...Nuevolution AB (SSE:NUE) for about $167 million in cash (see "Amgen Proposes to Acquire Partner Nuevolution"...
BioCentury | Jul 12, 2019
Financial News

HitGen joins growing Shanghai IPO queue

...myeloma. According to the company's prospectus, HitGen's partnerships outnumber those of competing DEL service companies Nuevolution...
...deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...
BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...Pfizer Inc. (NASDAQ:PFE) Array Biopharma Inc. (NASDAQ:ARRY) 06/17/19 $10,644.0 NA NA $10,644.0 Amgen Inc. (NASDAQ:AMGN) Nuevolution...
BioCentury | May 22, 2019
Company News

In a rare M&A move, Amgen proposes to acquire partner Nuevolution

...first acquisition since 2015, Amgen offered on Wednesday to buy Copenhagen-based small molecule discovery company Nuevolution...
...the deal would enable Amgen to more closely integrate Nuevolution's discovery platform into Amgen's research. Nuevolution's...
...million up front. Nuevolution gained SEK20.10 (166%) to SEK32.20 on Wednesday. Elizabeth S. Eaton, Staff Writer Amgen Inc. Nuevolution...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...whole industry.” Jin Li, HitGen HitGen has two principal competitors: Massachusetts-based X-Chem Inc. and Copenhagen-based Nuevolution...
...compounds, and has 22 collaborations, which have yielded more than 50 licenses to its partners. Nuevolution...
...what it considered the three leading companies in the DEL space -- HitGen, X-Chem and Nuevolution...
BioCentury | Jan 24, 2018
Company News

Management tracks: Gritstone, Disarm, Symic

...Billbäck, who was a senior advisor at Essity Aktiebolag (SSE:ESSITY). Small molecule drug discovery company Nuevolution...
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...and Phase I testing for renal diseases and AD. Two other companies, Dybly AG and Nuevolution...
...Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. MPM Capital, South San Francisco, Calif. Nuevolution...
Items per page:
1 - 10 of 54